Groups seek insurance for immunotherapy for lung cancer patients

Two cancer-related societies in Taiwan are urging the government to allow national health insurance to cover payment for immunotherapy for late-stage lung cancer patients without having such patients receive traditional chemotherapy first.

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)